IGM Biosciences Inc (IGMS)
9.38
-0.07
(-0.74%)
USD |
NASDAQ |
May 02, 16:00
9.38
0.00 (0.00%)
After-Hours: 17:06
IGM Biosciences Total Assets (Quarterly): 423.41M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 423.41M |
September 30, 2023 | 474.35M |
June 30, 2023 | 480.66M |
March 31, 2023 | 462.74M |
December 31, 2022 | 513.50M |
September 30, 2022 | 540.94M |
June 30, 2022 | 582.20M |
March 31, 2022 | 257.74M |
December 31, 2021 | 298.13M |
September 30, 2021 | 332.23M |
Date | Value |
---|---|
June 30, 2021 | 350.66M |
March 31, 2021 | 380.47M |
December 31, 2020 | 408.63M |
September 30, 2020 | 211.72M |
June 30, 2020 | 229.06M |
March 31, 2020 | 243.15M |
December 31, 2019 | 261.35M |
September 30, 2019 | 269.86M |
June 30, 2019 | 88.43M |
December 31, 2018 | 3.979M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
88.43M
Minimum
Jun 2019
582.20M
Maximum
Jun 2022
358.38M
Average
350.66M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
Inotiv Inc | 835.51M |
Synlogic Inc | 75.55M |
BioXcel Therapeutics Inc | 73.70M |
Xilio Therapeutics Inc | 60.93M |
NovaBay Pharmaceuticals Inc | 9.034M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 220.18M |
Shareholders Equity (Quarterly) | 203.23M |
Current Ratio | 8.182 |